Skip to search.
 TSX Down 1.79% TSX Ventures Up 0.02%

Titan Pharmaceuticals Inc. (TTNP)

-NasdaqCM
3.46 Down 0.38(9.90%) 4:00PM EST
Prev Close:3.84
Open:3.79
Bid:3.46 x 300
Ask:4.28 x 1000
1y Target Est:7.75
Beta:1.1576
Earnings Date:Mar 29 - Apr 4 (Est.)
Day's Range:3.45 - 3.98
52wk Range:2.57 - 10.00
Volume:171,184
Avg Vol (3m):230,495
Market Cap:69.41M
P/E (ttm):N/A
EPS (ttm):-0.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
TTNPDown 9.90%69.41M
LLYDown 0.17%78.57B
PFEDown 1.62%176.32B
JNJUp 1.45%282.23B

Key Statistics

Forward P/E (1 yr):13.84
P/S (ttm):29.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.54
Quarterly EPS Est (Dec-15) :-0.10
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback